Sharps Technology 8/14/2023 Earnings Report

Sharps Technology EPS Results

• Actual EPS: -$1,452.00
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Sharps Technology Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Sharps Technology Announcement Details

• Date: 8/14/2023
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.